Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05852275
Other study ID # Project nº 171-CES/UCP
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date May 30, 2023

Study information

Verified date May 2023
Source Universidade Católica Portuguesa
Contact Marta Correia, PhD
Phone 00351912633095
Email mmcorreia@ucp.pt
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research project, approved and funded, is part of a larger project, entitled "Healthy Soil for Food", which completes several work packages, one of which is a clinical research submitted to Ethics Committee entitled "O-LIVE: Impact of olive oil Portuguese in biomarkers of healthy volunteers". The main objective of this work is to evaluate the impact of ingestion of an olive oil rich in polyphenols on clinical biomarkers and parameters, such as anthropometric measurements, on inflammatory gene expression regulation and on the composition of the intestinal microbiota.


Description:

Olive oil is an ancient product that is crucial for social cohesion and for local economies in the Mediterranean region, particularly in Portugal. There is ample evidence on the protective effect of olive oil in cardiovascular disease, diabetes, oncological diseases and neurological degeneration. Furthermore, olive oil has been shown to increase the rate of oxidation, inhibiting lipogenesis and stimulating lipolysis, in addition to affecting the expression of receptors involved in weight regulation and fat use. These health benefits of olive oil derive from its specific nutritional composition, with monounsaturated fatty acids, polyphenols and phenolic compounds, which act on metabolism, modulation of inflammatory responses and gene expression. But the composition of olive oil can vary considerably depending on the type of cultivation of olive trees, soil management practices, as well as the extraction and technological processes involved in olive oil production. In this work the investigators will use an olive oil rich in polyphenols (produced in a sustainable and local manner) and evaluate its effect on several important clinical parameters involved in chronic diseases. The investigators anticipate that the results of this work will help support the relationship between consuming higher polyphenol olive oil and improved overall health.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date May 30, 2023
Est. primary completion date March 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Healthy volunteers Exclusion Criteria: - Current active infections - Medications (Antidepressant medication, Antibiotics, anti-inflammatory, Angiotensin Converting Enzyme inhibitors, insulin and oral anti-diabetic medication) - Dietary supplements (minerals and oligoelements, antioxidants, n-3 polyunsaturated fatty acids, n-6 polyunsaturated fatty acids, n-9 fatty acids) - Presence of ant chronic/metabolic diseases: - Diabetes - Cancer - Inflammatory diseases

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Olive-oil
Participants will add to their usual diet a daily intake of 30 mL of an olive oil rich in polyphenols for 3-months (100 days)

Locations

Country Name City State
Portugal Escola Superior de Biotecnologia, Universidade Católica Portuguesa Porto

Sponsors (1)

Lead Sponsor Collaborator
Universidade Católica Portuguesa

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body weight Body weight will be assessed using a scale Day 1
Primary Body weight Body weight will be assessed using a scale Day 50-60
Primary Body weight Body weight will be assessed using a scale Day 100
Primary Bacterial populations in fecal cultures Bacterial populations in fecal cultures will be analysed by microbial DNA extraction and quantitative real-time polymerase-chain reaction (PCR) using specific primers. Day 1
Primary Bacterial populations in fecal cultures Bacterial populations in fecal cultures will be analyzed by microbial DNA extraction and quantitative real-time polymerase-chain reaction (PCR) using specific primers. Day 100
Primary Inflammatory gene expression Saliva sample will also be collected for subsequent DNA extraction and application of quantitative real-time PCR to determine the expression of inflammatory genes. Day 1
Primary Inflammatory gene expression Saliva sample will also be collected for subsequent DNA extraction and application of quantitative real-time PCR to determine the expression of inflammatory genes. Day 100
Primary Body composition (% of fat mass and % of non-fat mass) Body composition will be assessed using Body Impedance Analysis (body composition analyser) Day 1
Primary Body composition (% of fat mass and % of non-fat mass) Body composition will be assessed using Body Impedance Analysis (body composition analyser) Day 100
Primary Adhesion to mediterranean diet PREDIMED (PREvencion con Diet MEDiterranea) is a brief 14-item tool able to capture a strong monotonic inverse association between adherence to a good quality dietary pattern (Mediterranean diet) and obesity indexes in a population of adults (doi:10.1371/journal.pone.0043134) Day 1
Primary Adhesion to mediterranean diet PREDIMED (PREvencion con Diet MEDiterranea) is a brief 14-item tool able to capture a strong monotonic inverse association between adherence to a good quality dietary pattern (Mediterranean diet) and obesity indexes in a population of adults (doi:10.1371/journal.pone.0043134) Day 50-60
Primary Adhesion to mediterranean diet PREDIMED (PREvencion con DIeta MEDiterranea) is a brief 14-item tool able to capture a strong monotonic inverse association between adherence to a good quality dietary pattern (Mediterranean diet) and obesity indexes in a population of adults (doi:10.1371/journal.pone.0043134) Day 100
Primary Lipid profile serum level A drop of blood will be analysed for biochemical parameters with point of care technology using a finger prick and analysed for total cholesterol, HDL, LDL and triacylglycerols Day 1
Primary Lipid profile serum level A drop of blood will be analysed for biochemical parameters with point of care technology using a finger prick and analysed for total cholesterol, HDL, LDL and triacylglycerols Day 100
Primary C-reactive Protein serum level A drop of blood will be analysed for biochemical parameters with point of care technology using a finger prick and analysed for PCR levels Day 1
Primary C-reactive Protein serum level A drop of blood will be analysed for biochemical parameters with point of care technology using a finger prick and analysed for PCR levels Day 100
Primary glycated hemoglobin A1c serum levels drop of blood will be analysed for biochemical parameters with point of care technology using a finger prick and analysed for levels glycated hemoglobin (ha1c) Day 1
Primary glycated hemoglobin A1c serum levels drop of blood will be analysed for biochemical parameters with point of care technology using a finger prick and analysed for levels glycated hemoglobin (ha1c) Day 100
See also
  Status Clinical Trial Phase
Completed NCT01885624 - Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers Phase 1
Recruiting NCT06204250 - A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers Phase 1
Completed NCT01495442 - Evaluation of a Dry Powder Aerosol Dispersion Mechanism by Radiolabeling Techniques N/A